📋 Tender Overview
Contract awarded for Framework agreement for the supply of medicines for ophthalmology, the respiratory system, and all other therapeutic products. lot-0012, title: combinations (tropicamide + phenylephrine + lidocaine) 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, description: acquisition of combinations (tropicamide + phenylephrine + lidocaine) 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, according to the specifications lot-0013, title: combinations (tobramycin and dexamethasone 3 mg/1 mg/ml eye drops), description: acquisition of combinations (tobramycin and dexamethasone 3 mg/1 mg/ml eye drops), according to the specifications lot-0034, title: travoprost 40 mcg/ml eye drops, description: acquisition of travoprost 40 mcg/ml eye drops, according to the specifications lot-0044, title: combinations (beclometasone + formoterol + glycopyrronium bromide) 87/5/9 micrograms per dose inhalation solution, description: acquisition of combinations (beclometasone + formoterol + glycopyrronium bromide) 87/5/9 micrograms per dose inhalation solution, according to the specifications lot-0058, title: combinations (beclometasone + formoterol) 100/6 micrograms per dose inhalation solution, description: acquisition of combinations (beclometasone + formoterol) 100/6 micrograms per dose inhalation solution, according to the specifications lot-0059, title: combinations (budesonide + formoterol) 160µg / 4.5µg, description: acquisition of combinations (budesonide + formoterol) 160µg / 4.5µg, according to the specifications lot-0060, title: combinations (budesonide + formoterol) 320/9 micrograms, description: acquisition of combinations (budesonide + formoterol) 320/9 micrograms, according to the specifications lot-0061, title: combinations (tiotropium + olodaterol) 2.5µg/2.5µg, description: acquisition of combinations (tiotropium + olodaterol) 2.5µg/2.5µg, according to the specifications lot-0062, title: combinations (formoterol + glycopyrronium + budesonide) 5 mcg/7.2 mcg/160 mcg x 120 doses, description: acquisition of combinations (formoterol + glycopyrronium + budesonide) 5 mcg/7.2 mcg/160 mcg x 120 doses, according to the specifications lot-0066, title: diphenhydramine 30 mg/2 ml injection solution, description: acquisition of diphenhydramine 30 mg/2 ml injection solution, according to the specifications lot-0087, title: naloxone 0.4 mg/ml injection/perfusion solution, description: acquisition of naloxone 0.4 mg/ml injection/perfusion solution, according to the specifications. estimated value excluding vat: 720.00 ron.Framework agreement for the supply of medicines for ophthalmology, the respiratory system, and all other therapeutic products.